Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
prolong ejaculation.
Popular Articles

China Quarantines New Orleans Mayor And Wife Over Swine Flu
Although they have no symptoms themselves, the mayor of New Orleans, Louisiana, USA, Ray Nagin, his wife and a member of his security staff
generic viagra
Divisions Emerge Among Democrats Lawmakers, Business Groups
As the health care debate intensifies, divisions among lawmakers, competing lobbies and interest groups are increasingly tense. "The health care battle in Congress is getting hotter, fueled by growing opposition to taxing health insurance benefits, mandating small-business coverage and cutting Medicare payments and by creeping doubts about a public plan for the uninsured. And this is just among Democrats," the Washington Times reports. Notably, last week the Blue Dog Coalition, a group of conservative Democrats, objected to the cost of an anticipated House reform proposal and said it would hurt small businesses, a key constituency already reeling from the recession. The objection stalled the House, which delayed releasing the proposal (Lambro, 7/14).
News of the day
Medimix International To Exhibit At American Society of Clinical Oncology AGM
Medimix International, a leader in global healthcare marketing research for life sciences industry, announced that it will be exhibiting at the 45th AGM of the American Society of Clinical Oncology, which will take place in Orlando, Florida from May 29-June 2, 2009. The annual ASCO meeting is considered to be the premier educational and scientific event in the oncology community, a forum for cutting-edge scientific and educational developments in oncology with a focus on personalizing cancer care.
Mental Health

A Canada-Wide Technology Platform For Mapping The Human Interactome

On June 18, the Canada Foundation for Innovation (CFI) announced the award of $9.16 million for the creation of a national technology platform aimed at mapping the human interactome. This national platform, headed by Dr. Benoit Coulombe from the Institut de recherches cliniques de Montrç©al (IRCM), will not only provide Canadian researchers with new state-of-the-art equipment in proteomics, functional genomics and bioinformatics, but also bring together integrated infrastructure for deciphering the human interactome an expertise that, until now, has been spread in 12 universities across Canada. Sequencing the human genome has revolutionized biomedical research. One of the major challenges that scientists throughout the world are facing in the post-genome era is the mapping of the interactome, which can be defined as the complete set of interaction networks underlying the functioning of our cells. The creation of a nation-wide platform will allow Canadian scientists to position themselves favorably in interactome research. In fact, a group of Canadian researchers led by Dr. Coulombe is currently working with American and European colleagues on the creation of an international project, the International Interactome Initiative (I3), aimed at developing new technologies and expertise to elucidate the interactome. "Canada has now a powerful tool that will allow its scientists to continue to take the lead in international research on the human interactome," mentioned Dr. Coulombe. "Thanks to this $22.9 million investment from the CFI and the other partners in this project, we will not only be able to gather detailed data allowing us to understand the interactome"s dynamic organization, but also combine the areas of expertise of some of our best scientists through a very promising multidisciplinary project for our country and our respective provinces and institutions." According to Dr. Coulombe, understanding the interactome"s organization by mapping the dynamic networks that proteins form when they interact together and with other molecules such as RNAs or DNA will allow us to better define the very bases of life and the misfunctions that lead to illness and eventually death. "There is even hope that this knowledge of the intricate molecular functioning of human cells will lead to the development of better treatments to fight against diseases," concluded the researcher. "Canadian scientists are at the forefront of research aimed at deciphering how proteins inside the cell interact, and how errors in this process underlie disease states. This generous funding from the CFI will allow leading scientific groups in Canada to collaborate in addressing this critical problem in biomedicine. This collaboration will greatly accelerate our ability to analyze the proteins within normal and diseased cells, and to comprehensively map out their interactions," added Dr. Anthony Pawson of The Samuel Lunenfeld Research Institute (SLRI) in Toronto and the recipient of several prestigious international awards such as the Gairdner Award (1994), the Wolf Prize (2005) and the Kyoto Prize (2008). Dr. Pawson is one of the scientists involved in the national platform project and the creation of the International Interactome Initiative (I3), along with Dr. Coulombe. "I am proud that the IRCM is coordinating such an important Canada-wide initiative under the leaderschip of Dr. Coulombe. The IRCM is fully committed to provide all necessary support for the success of this new technology platform," added Dr. Tarik Mç¶rç¶y, President and Scientific Director of the IRCM. In addition to the IRCM and The Samuel Lunenfeld Research Institute of Mount Sinai Hospital, four other institutions received infrastructure funding as part of this grant, which will allow them to acquire equipment that will complement the technologies currently available. These are: the Donnelly Centre for Cellular and Biomolecular Research (DCCBR) at the University of Toronto, the Ottawa Institute of Systems Biology (OISB) at the University of Ottawa, the Universitç© de Sherbrooke, and Dalhousie University Dr. Benoit Coulombe is Full Research Professor IRCM, Director of the Research Unit on Gene Transcription and Proteomics and Director of the Proteomics Discovery Platform at the IRCM. He is also Full Professor in the Department of Biochemistry at the Universitç© de Montrç©al and is accredited in molecular biology at that same university. Benoit Coulombe Institut de recherches cliniques de Montreal


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009